486.04MMarket Cap-28.05P/E (TTM)
3.115High2.860Low1.29MVolume2.980Open3.020Pre Close3.88MTurnover1.27%Turnover RatioLossP/E (Static)157.55MShares4.83052wk High3.17P/B313.46MFloat Cap2.01052wk Low--Dividend TTM101.61MShs Float12.900Historical High--Div YieldTTM8.44%Amplitude1.570Historical Low3.002Avg Price1Lot Size
Evolv Technologies Stock Forum
Gapping Up
$Corcept Therapeutics (CORT.US)$ surged over 60% after the company announced that its Phase 3 trial, ROSELLA, met its primary endpoint, improving progression-free survival in platinum-resistant ovarian cancer patients.
$QuantaSing Group (QSG.US)$ surged 20.18% in pre-market trading following a 12% increase on Friday. Last week, QuantaSing Group expanded into the pop toys market through the strategic acqui...
Evolv Technology Lands Full Stadium Deal with Seattle Mariners, Now Powers 12 MLB Teams
3 MINUTES AGO, 8:00 AM EST
VIA BUSINESSWIRE
Dow Jones· 1 min ago
Evolv Technologies Surpassed 6,000 Evolv Express Units Deployed Globally With Activation of About 470 New Multi-Yr Subscriptions >EVLV
Dow Jones· 2 mins ago
Evolv Receives Expected Nasdaq Delinquency Notification
No comment yet